Researchers from St. Jude Children’s Research Hospital have discovered that inhibiting an enzyme called cyclin-dependent kinase 2 (CDK2) protects mice and rats from noise- or drug-induced hearing loss. The study, which will be published March 7 in the Journal of Experimental Medicine, suggests that CDK2 inhibitors prevent the death of inner ear cells, which has the potential to save the hearing of millions of people around the world.
According to the World Health Organization, 360 million people worldwide, including 32 million children, suffer from hearing loss caused by congenital defects or other factors. These factors include infectious disease, use of certain medicines, or exposure to excessive noise. Yet, there are currently no FDA-approved drugs to prevent or treat hearing loss.
A team of researchers led by Dr. Jian Zuo screened over 4,000 drugs for their ability to protect cochlear cells from the chemotherapy agent cisplatin. Cisplatin is used to treat a variety of cancers but causes irreversible hearing loss in up to 70% of patients.
Zuo and colleagues identified multiple compounds that protected cochlear cells from cisplatin, several of which are already approved to treat other conditions. Three of the ten most effective compounds were inhibitors of an enzyme called CDK2. One of these CDK2 inhibitors, kenpaullone, was more effective than four other compounds that are currently in clinical trials for treating hearing loss.
Injecting kenpaullone into the middle ear protected both mice and rats from cisplatin-induced hearing loss. Moreover, kenpaullone also protected the hearing of mice to noise as loud as 100 dB. “Given that 100-dB noise is in the range of noise insults commonly experienced by people in our society, kenpaullone could have significant clinical application in treating noise-induced hearing loss,” says Zuo.
In the case of cisplatin-induced hearing loss, kenpaullone appears to protect hair cells by preventing CDK2 from stimulating the production of toxic reactive oxygen species from the cells’ mitochondria.
“The robust protection conferred by one-time local delivery of kenpaullone suggests that CDK2 inhibitors may transform the clinical prevention and treatment of cisplatin- and noise-induced hearing loss in patients,” Zuo says. “Modifications of the treatment regimens, additional optimization of the delivery methods via the use of hydrogels, and structural modifications of the compounds via medicinal chemistry could ensure even better results with CDK2 inhibitors in treating hearing loss in humans.”
The Latest on: Hearing loss
- Why sudden hearing loss should not be ignored on December 15, 2018 at 11:13 am
Sudden sensorineural hearing loss (SSHL) is a type of hearing loss that occurs suddenly in the inner/middle ear. Patients usually notice a decline in their hearing after hearing a sudden “pop” or afte... […]
- Hearing loss charity urges people attending Christmas parties to wear earplugs on December 14, 2018 at 4:24 pm
PEOPLE attending festive parties have been urged to wear earplugs to protect their hearing. As the Christmas party season gets into full swing, charity Action on Hearing Loss is encouraging people to ... […]
- Destigmatizing Hearing Loss with Technology: Interview with Eargo CEO Christian Gormsen on December 14, 2018 at 9:00 am
Today, 500 million people globally suffer from hearing loss, however, most individuals wait on average seven years before dealing with the condition due to a combination of factors, including stigmas ... […]
- Unaddressed hearing loss costs $750b yearly on December 13, 2018 at 3:02 pm
UNADDRESSED hearing loss poses an annual global cost of US$ 750 billion, a report has indicated. Kemi Remi-Dairo Hearing Foundation, a non-profit organisation with the aim of providing medical ... […]
- Why hearing loss affects much more than your ears on December 13, 2018 at 5:40 am
If you are not taking proper care of your hearing, thinking that hearing loss is not such a big deal and will only affect your ears, you are wrong. Suffering from hearing loss, but not treating it pro... […]
- Hearing loss could increase likelihood of premature death on December 13, 2018 at 4:26 am
For many consumers, experiencing hearing loss is a sign of old age, though oftentimes, many suspect it’s nothing more serious. However, based on a new study conducted by researchers from Columbia Univ... […]
- Using earphones for THIS long can lead to hearing loss on December 13, 2018 at 4:02 am
From Aishwarya Rai to Kareena Kapoor: Who wore what at Isha Ambani and Anand Piramal's wedding From Janhvi Kapoor to Deepika Padukone: Who wore what at Isha Ambani's sangeet 10 photos of Miss ... […]
- Hearing Loss May Up Premature Death Risk on December 12, 2018 at 9:39 pm
People with hearing loss are more likely to die early, reports a new study. The findings of the study are published in the journal Social Science and Medicine. A new study links hearing loss with an i... […]
- Hearing loss is a risk factor for premature death on December 12, 2018 at 9:53 am
A new study links hearing loss with an increased risk for mortality before the age of 75 due to cardiovascular disease. Researchers found that mortality among those with hearing loss is elevated, part... […]
- Study links occupational hearing loss to faster aging of auditory system on December 11, 2018 at 1:44 pm
Montreal — Noise exposure in the workplace can accelerate presbycusis https://www.nidcd.nih.gov/sites/default/files/Content%20Images/presbycusis.pdf – the normal loss of hearing as a result of aging – ... […]
via Google News and Bing News